Evidence map›Paper›PMID 42179596›Full record

ArticleACS omega2026

Halogenated Reagents in the Ugi Reaction: From Rearrangement Reactions to Ketal Synthesis.

Beatriz González-Saiz, Carlos Cámara-Herrero, Sandra Díaz-Cabrera, Israel Carreira-Barral, Roberto Quesada, María García-Valverde

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Beatriz González-SaizDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Burgos 09001, Spain.
Carlos Cámara-HerreroDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0009-0009-1010-0682
Sandra Díaz-CabreraDigital Department of Biomedical and Health Sciences, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid 28670, Spain.ORCID https://orcid.org/0000-0002-0005-782X
Israel Carreira-BarralDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0000-0002-4835-8752
Roberto QuesadaDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0000-0003-2764-7157
María García-ValverdeDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, Burgos 09001, Spain.ORCID https://orcid.org/0000-0002-3990-8388

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The morpholine scaffold constitutes a privileged structural motif in medicinal chemistry, although access to conformationally restricted systems remains challenging. Herein, we report a simple and efficient Ugi/postcondensation strategy that, for the first time, combines two aliphatic halogenated reagents with arylglyoxals to afford fused and bridged morpholines bearing ketal functionalities in a diastereoselective manner. These derivatives serve as precursors to 4-hydroxypyroglutamic acid derivatives, highlighting the synthetic versatility of the approach and providing rapid entry to structurally complex heterocyclic derivatives.

Identifiers

PMID42179596
PMCPMC13191683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.